• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/15 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/15

Total number of patents in this class: 335

10-year publication summary

25
35
17
26
18
20
23
29
27
25
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The Board of Trustees of the University of Illinois
2714
13
The Board of Regents of the University of Texas System
2216
9
Tetraphase Pharmaceuticals, Inc.
51
8
Novartis AG
10725
6
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1345
6
Pharmatrophix, Inc.
22
5
Ramot at Tel-Aviv University Ltd.
1487
5
University of Tennessee Research Foundation
752
5
Beam Therapeutics Inc.
244
5
Contemporary Amperex Technology (Hong Kong) Limited
3744
5
Rohm and Haas Company
2900
4
Dow Global Technologies LLC
10413
4
President and Fellows of Harvard College
5998
4
JSR Corporation
2530
4
West China Hospital, Sichuan University
200
4
Sanofi
4093
4
BASF SE
20991
3
Massachusetts Institute of Technology
10110
3
Korea Institute of Science and Technology
2137
3
Canopy Growth Corporation
223
3
Other owners 232